Direct passive hemagglutination test for rapid  quantification of plasma load of the Human  Immunodeficiency Virus

doi:10.4236/health.2013.59183

Home > Journals > Biomedical & Life Sciences | Medicine & Healthcare > Health

Health> Vol.5 No.9, September 2013

Share This Article:

Open Access

Direct passive hemagglutination test for rapid quantification of plasma load of the Human Immunodeficiency Virus

Full-Text HTML

Download as PDF (Size:154KB) PP. 1351-1354

DOI: 10.4236/health.2013.59183 3,300 Downloads 5,226 Views Citations

Author(s) Leave a comment

Maduike C. O. Ezeibe, Augustine A. Ngene, Ifeanyichukwu Anene, Bridget Amechi, Peter Olowoniyi, James I. Eze, Paul C. Animoke

Affiliation(s)

Department of Veterinary Medicine, University of Nigeria, Nsukka, Nigeria;.
Federal Medical Centre, Umuahia, Nigeria.

ABSTRACT

An inexpensive and rapid test for determining titers of Human Immunodeficiency Virus (HIV) in plasmas was developed. Washed sheep red blood cells were applied onto HIV positive plasmas, in V-bottomed microtiter plates, to complement the HIV antigens and antibodies present in plasmas. The setup was incubated for 30 minutes at 37℃. Reciprocal of the highest dilution of each plasma which gave passive agglutination of the RBCs was read as its HIV titer. Mean HIV load of five samples, was ≥ 4096.00 ± 0.00 after one day of storage at 4℃ but it reduced to 256.00 ± 70.10, 28.80 ± 3.20, 7.20 ± 0.80 and 1.60 ± 0.98 on days 2, 3, 4 and 7, respectively. HIV antibodies were still detectable, by ELISA, in plasma dilutions that were tested negative with the new test. It was concluded that when HIV antibodies have been confirmed, or added to plasmas, passive hemagglutination test can be applied to assess their viral loads.

KEYWORDS

HIV; Antibodies; Antigens; Plasma; Sheep Red Blood Cells

Cite this paper

Ezeibe, M. , Ngene, A. , Anene, I. , Amechi, B. , Olowoniyi, P. , Eze, J. and Animoke, P. (2013) Direct passive hemagglutination test for rapid quantification of plasma load of the Human Immunodeficiency Virus. Health, 5, 1351-1354. doi: 10.4236/health.2013.59183.

References

[1]	World health Organization (2007) Laboratory guidelines for enumerating CD4 T lymphocytes in the contest of HIV/AIDS. World Health Organization Regional Office for South-East Asia, New Delhi.

[2]	Arya, S.C., Pathak, V.P., Ashrat, S.J. and Ashrat, S.K. (1989) Passive hemagglutination test for detection of antibodies of the Human Immunodeficiency Virus type 1 in developing countries. Journal of Clinical Microbiology, 27, 170-174.

[3]	www.hivinfosource.org.

[4]	Vasudevachari, M.B., Ulfelman, K.W., Mast, T.C., Dewar, R.C., Natarajar, N., Lane, H.C. and Salzman, N.P. (1989) Passive hemagglutination test for detection of antibodies to the Human Immunedeficiency Virus type 1 and comparism of the test with ELISA and Western blot (Immunoblot) analysis. Journal of Clinical Microbiology, 27, 179-181.

[5]	Ezeibe, M.C.O, Okoye, J.O.A., Ogunniran, T..M, Okoroafor, O.N., Ezeala, I.E., Ngene, A.A. (2012) Modification of the passive heamagglutination test for detection of Infectious Bursa Disease Virus. Health, 4, 653-655. doi:10.4236/health.2012.49102

[6]	Wosu, L.O. (1984) Standardization of red blood cells for haemagglutination test and removal of natural agglutinins. Nigerian Veterinary Journal, 13, 39-42.

[7]	World Health Organization (2004) Consultation on technical and operational recommendations for scale-up of laboratory services and monitoring HIV antiretroviral therapy in resource-limited settings. WHO Office, Geneva.

[8]	Center for Disease Control (2010) Cdc.gov/mmwr/preview/mmwrhtm